NCT04166825 Ovarian Hyperstimulation and Fibrin Clot Properties.
| NCT ID | NCT04166825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jagiellonian University |
| Condition | Fibrin Blood Clot |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2019-11-18 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2019-11-18 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The impact evaluation of ovarian hyperstimulation on coagulation and fibrinolysis in infertile women. Comparative analysis between different ovarian stimulation protocols on thrombin formation and efficiency of fibrinolysis in women diagnosed with infertility.
Eligibility Criteria
Inclusion Criteria: * infertility defined based on the WHO 2010 criteria Exclusion Criteria: * ovarian involvement * oral contraceptives use within previous 3 months * dienogest therapy within 3 months until ART * thrombotic events in the medical history * severe hypertension * diabetes mellitus * the presence of known VTE risk factors, including obesity, recent major surgery with prolonged immobilization or trauma, * deficiency of antithrombin, protein C or protein S, * antiphospholipid syndrome, * known malignancy, * any chronic inflammatory diseases (e.g. rheumatoid arthritis) * advanced chronic renal disease (estimated glomerular filtration rate \[eGFR\] \<30 ml/min), * international normalized ratio (INR) more than 1.2 at the day of blood draw * pregnancy.
Frequently Asked Questions
Who can join the NCT04166825 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Fibrin Blood Clot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04166825 currently recruiting?
Yes, NCT04166825 is actively recruiting participants. Visit ClinicalTrials.gov or contact Jagiellonian University to inquire about joining.
Where is the NCT04166825 trial being conducted?
This trial is being conducted at Krakow, Poland.
Who is sponsoring the NCT04166825 clinical trial?
NCT04166825 is sponsored by Jagiellonian University. The trial plans to enroll 300 participants.